バイオテクネの四半期報告

http://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense0000842023--06-302024Q3falsehttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrentBIO-TECHNE Corphttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#SellingGeneralAndAdministrativeExpense0000842023us-gaap:CommonStockMember2023-10-012023-12-310000842023us-gaap:CommonStockMember2022-10-012022-12-310000842023us-gaap:CommonStockMember2024-01-012024-03-310000842023us-gaap:CommonStockMember2023-07-012023-09-300000842023us-gaap:CommonStockMember2023-01-012023-03-310000842023us-gaap:CommonStockMember2022-07-012022-09-300000842023us-gaap:RetainedEarningsMember2024-03-310000842023us-gaap:AdditionalPaidInCapitalMember2024-03-310000842023us-gaap:RetainedEarningsMember2023-12-310000842023us-gaap:AdditionalPaidInCapitalMember2023-12-310000842023us-gaap:RetainedEarningsMember2023-09-300000842023us-gaap:AdditionalPaidInCapitalMember2023-09-300000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000008420232023-09-300000842023us-gaap:RetainedEarningsMember2023-06-300000842023us-gaap:AdditionalPaidInCapitalMember2023-06-300000842023us-gaap:RetainedEarningsMember2023-03-310000842023us-gaap:AdditionalPaidInCapitalMember2023-03-310000842023us-gaap:RetainedEarningsMember2022-12-310000842023us-gaap:AdditionalPaidInCapitalMember2022-12-3100008420232022-12-310000842023us-gaap:RetainedEarningsMember2022-09-300000842023us-gaap:AdditionalPaidInCapitalMember2022-09-300000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-3000008420232022-09-300000842023us-gaap:RetainedEarningsMember2022-06-300000842023us-gaap:NoncontrollingInterestMember2022-06-300000842023us-gaap:AdditionalPaidInCapitalMember2022-06-300000842023us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-03-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300000842023us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300000842023tech:EmployeeStockPurchasePlan2014Member2014-10-300000842023us-gaap:RestrictedStockUnitsRSUMember2023-07-012024-03-310000842023us-gaap:RestrictedStockMember2023-07-012024-03-310000842023us-gaap:RestrictedStockUnitsRSUMember2022-07-012023-03-310000842023us-gaap:RestrictedStockMember2022-07-012023-03-310000842023us-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2023-07-012024-03-310000842023tech:QTHoldingsCorporationMembertech:ProteinSciencesMember2023-07-012024-03-310000842023us-gaap:ServiceMember2024-01-012024-03-310000842023us-gaap:RoyaltyMember2024-01-012024-03-310000842023us-gaap:IntersegmentEliminationMember2024-01-012024-03-310000842023tech:RestOfWorldMember2024-01-012024-03-310000842023tech:ProductAndServicesMember2024-01-012024-03-310000842023tech:OtherRevenuesFromBusinessHeldForSaleMember2024-01-012024-03-310000842023tech:InstrumentsMember2024-01-012024-03-310000842023tech:EMEAExcludingUKMember2024-01-012024-03-310000842023tech:ConsumablesMember2024-01-012024-03-310000842023tech:APACExcludingGreaterChinaMember2024-01-012024-03-310000842023country:US2024-01-012024-03-310000842023country:GB2024-01-012024-03-310000842023us-gaap:ServiceMember2023-07-012024-03-310000842023us-gaap:RoyaltyMember2023-07-012024-03-310000842023us-gaap:IntersegmentEliminationMember2023-07-012024-03-310000842023tech:RestOfWorldMember2023-07-012024-03-310000842023tech:ProductAndServicesMember2023-07-012024-03-310000842023tech:OtherRevenuesFromBusinessHeldForSaleMember2023-07-012024-03-310000842023tech:InstrumentsMember2023-07-012024-03-310000842023tech:EMEAExcludingUKMember2023-07-012024-03-310000842023tech:ConsumablesMember2023-07-012024-03-310000842023tech:APACExcludingGreaterChinaMember2023-07-012024-03-310000842023country:US2023-07-012024-03-310000842023country:GB2023-07-012024-03-310000842023us-gaap:ServiceMember2023-01-012023-03-310000842023us-gaap:RoyaltyMember2023-01-012023-03-310000842023us-gaap:IntersegmentEliminationMember2023-01-012023-03-310000842023tech:RestOfWorldMember2023-01-012023-03-310000842023tech:ProductAndServicesMember2023-01-012023-03-310000842023tech:InstrumentsMember2023-01-012023-03-310000842023tech:EMEAExcludingUKMember2023-01-012023-03-310000842023tech:ConsumablesMember2023-01-012023-03-310000842023tech:APACExcludingGreaterChinaMember2023-01-012023-03-310000842023country:US2023-01-012023-03-310000842023country:GB2023-01-012023-03-310000842023us-gaap:ServiceMember2022-07-012023-03-310000842023us-gaap:RoyaltyMember2022-07-012023-03-310000842023us-gaap:IntersegmentEliminationMember2022-07-012023-03-310000842023tech:RestOfWorldMember2022-07-012023-03-310000842023tech:ProductAndServicesMember2022-07-012023-03-310000842023tech:InstrumentsMember2022-07-012023-03-310000842023tech:EMEAExcludingUKMember2022-07-012023-03-310000842023tech:ConsumablesMember2022-07-012023-03-310000842023tech:APACExcludingGreaterChinaMember2022-07-012023-03-310000842023country:US2022-07-012023-03-310000842023country:GB2022-07-012023-03-310000842023tech:ChangzhouEminenceBiotechnologyMembertech:ProteinSciencesMember2022-07-012022-09-300000842023us-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2024-03-310000842023us-gaap:EmployeeSeveranceMember2024-03-310000842023us-gaap:EmployeeSeveranceMember2023-12-310000842023tech:AssetRelatedAndOtherMember2023-12-3100008420232023-12-310000842023us-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2023-06-300000842023tech:ImpairmentOfAssetsHeldForSaleMember2023-10-012023-12-310000842023tech:QTHoldingsCorporationMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2022-07-012023-06-300000842023tech:QTHoldingsCorporationMemberus-gaap:SellingGeneralAndAdministrativeExpensesMembertech:AssetImpairmentMembertech:ProteinSciencesMember2022-07-012023-06-300000842023tech:QTHoldingsCorporationMemberus-gaap:SellingGeneralAndAdministrativeExpensesMembertech:ProteinSciencesMember2022-07-012023-06-300000842023tech:QTHoldingsCorporationMemberus-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2022-07-012022-09-300000842023tech:QTHoldingsCorporationMembertech:AssetImpairmentMembertech:ProteinSciencesMember2022-07-012022-09-300000842023tech:QTHoldingsCorporationMembertech:ProteinSciencesMember2022-07-012022-09-300000842023us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000842023us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012024-03-310000842023us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000842023us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012023-03-310000842023us-gaap:MachineryAndEquipmentMember2024-03-310000842023us-gaap:LandMember2024-03-310000842023us-gaap:ConstructionInProgressMember2024-03-310000842023us-gaap:BuildingAndBuildingImprovementsMember2024-03-310000842023us-gaap:MachineryAndEquipmentMember2023-06-300000842023us-gaap:LandMember2023-06-300000842023us-gaap:ConstructionInProgressMember2023-06-300000842023us-gaap:BuildingAndBuildingImprovementsMember2023-06-300000842023tech:ChangzhouEminenceBiotechnologyMember2022-09-012022-09-010000842023tech:WilsonWolfCorporationMember2023-03-312023-03-310000842023tech:WilsonWolfCorporationMember2021-12-012021-12-310000842023us-gaap:EmployeeSeveranceMember2023-10-012023-12-310000842023tech:AssetRelatedAndOtherMember2023-10-012023-12-310000842023tech:QTHoldingsCorporationMemberus-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2022-10-012023-06-300000842023tech:QTHoldingsCorporationMembertech:AssetImpairmentMembertech:ProteinSciencesMember2022-10-012023-06-300000842023tech:QTHoldingsCorporationMembertech:ProteinSciencesMember2022-10-012023-06-300000842023us-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2022-07-012023-06-300000842023us-gaap:OperatingSegmentsMembertech:ProteinSciencesMember2024-01-012024-03-310000842023us-gaap:OperatingSegmentsMembertech:DiagnosticsAndGenomicsMember2024-01-012024-03-310000842023us-gaap:OperatingSegmentsMembertech:ProteinSciencesMember2023-07-012024-03-310000842023us-gaap:OperatingSegmentsMembertech:DiagnosticsAndGenomicsMember2023-07-012024-03-310000842023us-gaap:OperatingSegmentsMembertech:ProteinSciencesMember2023-01-012023-03-310000842023us-gaap:OperatingSegmentsMembertech:DiagnosticsAndGenomicsMember2023-01-012023-03-310000842023us-gaap:OperatingSegmentsMembertech:ProteinSciencesMember2022-07-012023-03-310000842023us-gaap:OperatingSegmentsMembertech:DiagnosticsAndGenomicsMember2022-07-012023-03-310000842023us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-03-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-03-310000842023us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-03-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-03-310000842023us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012024-03-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012024-03-310000842023us-gaap:DesignatedAsHedgingInstrumentMember2023-07-012024-03-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012024-03-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012024-03-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000842023us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012023-03-310000842023us-gaap:DesignatedAsHedgingInstrumentMember2022-07-012023-03-310000842023us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012023-03-310000842023us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012023-03-310000842023tech:AmendedCreditAgreementMember2024-03-310000842023us-gaap:RevolvingCreditFacilityMembertech:AmendedCreditAgreementMember2022-08-312022-08-310000842023srt:MaximumMember2024-03-310000842023us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000842023us-gaap:CertificatesOfDepositMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000842023tech:ExchangedTradedSecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023tech:ExchangedTradedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023tech:ExchangeTradedInvestmentGradeBondFundsMember2023-06-300000842023tech:WilsonWolfCorporationMember2024-01-012024-03-310000842023tech:WilsonWolfCorporationMember2023-07-012024-03-310000842023tech:ProteinSciencesMember2024-03-310000842023tech:DiagnosticsAndGenomicsMember2024-03-310000842023tech:ProteinSciencesMember2023-06-300000842023tech:DiagnosticsAndGenomicsMember2023-06-300000842023tech:ExchangedTradedSecuritiesMember2023-07-012024-03-310000842023tech:EminenceMember2022-07-012023-03-310000842023tech:ChemocentryxMember2022-07-012023-03-310000842023tech:ChangzhouEminenceBiotechnologyMemberus-gaap:NonoperatingIncomeExpenseMember2022-07-012022-09-300000842023srt:MinimumMembertech:LunaphoreTechnologiesSaMemberus-gaap:TradeNamesMember2024-03-310000842023srt:MaximumMembertech:LunaphoreTechnologiesSaMemberus-gaap:TradeNamesMember2024-03-310000842023us-gaap:TradeNamesMember2024-03-310000842023us-gaap:PatentsMember2024-03-310000842023us-gaap:OtherIntangibleAssetsMember2024-03-310000842023us-gaap:DevelopedTechnologyRightsMember2024-03-310000842023us-gaap:CustomerRelationshipsMember2024-03-310000842023us-gaap:TradeNamesMember2023-06-300000842023us-gaap:PatentsMember2023-06-300000842023us-gaap:OtherIntangibleAssetsMember2023-06-300000842023us-gaap:DevelopedTechnologyRightsMember2023-06-300000842023us-gaap:CustomerRelationshipsMember2023-06-300000842023us-gaap:FairValueInputsLevel3Membertech:ContingentConsiderationMember2024-01-012024-03-310000842023us-gaap:FairValueInputsLevel3Membertech:ContingentConsiderationMember2023-06-300000842023us-gaap:FairValueInputsLevel3Membertech:ContingentConsiderationMember2023-07-012024-03-310000842023tech:WilsonWolfCorporationMember2023-03-310000842023tech:WilsonWolfCorporationMember2023-06-300000842023us-gaap:RetainedEarningsMember2024-01-012024-03-310000842023us-gaap:RetainedEarningsMember2023-10-012023-12-310000842023us-gaap:RetainedEarningsMember2023-07-012023-09-300000842023us-gaap:RetainedEarningsMember2023-01-012023-03-310000842023us-gaap:RetainedEarningsMember2022-10-012022-12-310000842023us-gaap:RetainedEarningsMember2022-07-012022-09-300000842023tech:CurrentAssetsHeldForSaleMembertech:ProteinSciencesMember2024-03-310000842023tech:ProteinSciencesMember2023-12-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-05-310000842023us-gaap:CashFlowHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000842023us-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023us-gaap:CashFlowHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-03-310000842023tech:ForwardStartingSwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-06-300000842023us-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012024-03-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012023-03-310000842023us-gaap:CommonStockMember2024-03-310000842023us-gaap:CommonStockMember2023-12-310000842023us-gaap:CommonStockMember2023-09-300000842023us-gaap:CommonStockMember2023-06-300000842023us-gaap:CommonStockMember2023-03-310000842023us-gaap:CommonStockMember2022-12-310000842023us-gaap:CommonStockMember2022-09-300000842023us-gaap:CommonStockMember2022-06-3000008420232023-03-3100008420232022-06-300000842023tech:LunaphoreTechnologiesSaMemberus-gaap:TradeNamesMember2024-03-310000842023tech:LunaphoreTechnologiesSaMemberus-gaap:DevelopedTechnologyRightsMember2024-03-310000842023tech:LunaphoreTechnologiesSaMemberus-gaap:CustomerRelationshipsMember2024-03-310000842023tech:LunaphoreTechnologiesSaMember2024-01-012024-03-310000842023us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023tech:NamocellIncMember2023-06-300000842023tech:AcquisitionOfAsuragenIncMember2023-06-300000842023tech:NamocellIncMember2022-07-010000842023tech:AcquisitionOfAsuragenIncMember2021-04-060000842023tech:NamocellIncMember2023-12-310000842023tech:AcquisitionOfAsuragenIncMember2023-12-310000842023tech:LunaphoreTechnologiesSaMember2023-07-072023-07-070000842023tech:LunaphoreTechnologiesSaMember2023-07-012024-03-310000842023us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-03-310000842023us-gaap:FairValueMeasurementsRecurringMember2024-03-310000842023us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023us-gaap:FairValueMeasurementsRecurringMember2023-06-300000842023us-gaap:SellingGeneralAndAdministrativeExpensesMembertech:ProteinSciencesMember2023-07-012024-03-310000842023tech:EmployeeStockPurchasePlan2014Member2024-01-012024-03-310000842023tech:EmployeeStockPurchasePlan2014Member2023-07-012024-03-310000842023us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310000842023us-gaap:CostOfSalesMember2023-01-012023-03-310000842023tech:EmployeeStockPurchasePlan2014Member2023-01-012023-03-310000842023us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012023-03-310000842023us-gaap:CostOfSalesMember2022-07-012023-03-310000842023tech:EmployeeStockPurchasePlan2014Member2022-07-012023-03-310000842023us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000842023us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310000842023us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000842023us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000842023us-gaap:AdditionalPaidInCapitalMember2022-10-012022-12-310000842023us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000842023us-gaap:EmployeeSeveranceMemberus-gaap:CorporateMember2024-01-012024-03-310000842023us-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2024-01-012024-03-310000842023us-gaap:EmployeeSeveranceMembertech:DiagnosticsAndGenomicsMember2024-01-012024-03-310000842023tech:AssetRelatedAndOtherMemberus-gaap:CorporateMember2024-01-012024-03-310000842023tech:AssetRelatedAndOtherMembertech:ProteinSciencesMember2024-01-012024-03-310000842023tech:AssetRelatedAndOtherMembertech:DiagnosticsAndGenomicsMember2024-01-012024-03-310000842023us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-03-310000842023us-gaap:EmployeeSeveranceMember2024-01-012024-03-310000842023us-gaap:CostOfSalesMember2024-01-012024-03-310000842023us-gaap:CorporateMember2024-01-012024-03-310000842023tech:ProteinSciencesMember2024-01-012024-03-310000842023tech:DiagnosticsAndGenomicsMember2024-01-012024-03-310000842023tech:AssetRelatedAndOtherMember2024-01-012024-03-310000842023us-gaap:EmployeeSeveranceMemberus-gaap:CorporateMember2023-07-012024-03-310000842023us-gaap:EmployeeSeveranceMembertech:ProteinSciencesMember2023-07-012024-03-310000842023us-gaap:EmployeeSeveranceMembertech:DiagnosticsAndGenomicsMember2023-07-012024-03-310000842023tech:ImpairmentOfAssetsHeldForSaleMembertech:ProteinSciencesMember2023-07-012024-03-310000842023tech:AssetRelatedAndOtherMemberus-gaap:CorporateMember2023-07-012024-03-310000842023tech:AssetRelatedAndOtherMembertech:ProteinSciencesMember2023-07-012024-03-310000842023tech:AssetRelatedAndOtherMembertech:DiagnosticsAndGenomicsMember2023-07-012024-03-310000842023us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012024-03-310000842023us-gaap:EmployeeSeveranceMember2023-07-012024-03-310000842023us-gaap:CostOfSalesMember2023-07-012024-03-310000842023us-gaap:CorporateMember2023-07-012024-03-310000842023tech:ImpairmentOfAssetsHeldForSaleMember2023-07-012024-03-310000842023tech:DiagnosticsAndGenomicsMember2023-07-012024-03-310000842023tech:AssetRelatedAndOtherMember2023-07-012024-03-310000842023tech:QTHoldingsCorporationMembertech:ProteinSciencesMember2022-07-012023-06-300000842023tech:ProteinSciencesMember2022-07-012023-06-300000842023us-gaap:NoncontrollingInterestMember2022-07-012022-09-300000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-3100008420232023-10-012023-12-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-3000008420232023-07-012023-09-300000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-012022-12-3100008420232022-10-012022-12-310000842023us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-3000008420232022-07-012022-09-300000842023us-gaap:RevolvingCreditFacilityMembertech:AmendedCreditAgreementMember2022-08-310000842023us-gaap:OtherNoncurrentAssetsMember2024-03-310000842023us-gaap:OtherNoncurrentAssetsMember2023-06-300000842023country:CN2024-01-012024-03-310000842023country:CN2023-07-012024-03-310000842023country:CN2023-01-012023-03-3100008420232023-01-012023-03-310000842023country:CN2022-07-012023-03-310000842023tech:ProteinSciencesMember2023-07-012024-03-310000842023tech:WilsonWolfCorporationMember2024-03-310000842023tech:WilsonWolfCorporationMembertech:FirstPartOfForwardContractMember2024-03-310000842023tech:WilsonWolfCorporationMembertech:SecondPartOfForwardContractMember2024-03-3100008420232022-07-012023-03-310000842023us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-310000842023us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-07-310000842023tech:LunaphoreTechnologiesSaMember2024-03-3100008420232024-03-3100008420232023-06-300000842023us-gaap:OperatingSegmentsMember2024-01-012024-03-310000842023us-gaap:OperatingSegmentsMember2023-07-012024-03-310000842023us-gaap:OperatingSegmentsMember2023-01-012023-03-310000842023us-gaap:OperatingSegmentsMember2022-07-012023-03-3100008420232024-01-012024-03-3100008420232024-05-0100008420232023-07-012024-03-31xbrli:sharesiso4217:USDtech:itemxbrli:pureiso4217:USDxbrli:sharestech:segment


ミネソタ	41-1427402
(の州またはその他の管轄区域 incorporation or organization)	(I.R.S. Employer Identification No.)

614 McKinley Place N.E. Minneapolis, MN 55413	(612) 379-8854
(最高経営責任者の住所）（郵便番号)	(登録者の電話番号（市外局番を含む)


Title of each class	Trading Symbol(s)	登録されている各取引所の名称
普通株式、額面0.01ドル	TECH	the nasdaq stock market llc


Large accelerated filer	☒	Accelerated filer	☐

Non-accelerated filer	☐	Smaller reporting company	☐

		Emerging growth company	☐


		Page
パートi. 財務情報

Item 1.	要約連結財務諸表(監査対象外)	1

Item 2.	経営陣による財政状態および経営成績の検討と分析	27

Item 3.	市場リスクに関する定量的および定性的な開示	36

Item 4.	Controls and Procedures	37

パート ii: その他の情報

Item 1.	Legal Proceedings	37

Item 1A.	Risk Factors	37

Item 2.	持分証券の無登録販売とその代金の使途について	38

Item 3.	優先出資証券の債務不履行	38

Item 4.	Mine Safety Disclosures	38

Item 5.	Other Information	38

Item 6.	Exhibits	39

	SIGNATURES	42